By coating tiny gel beads with lung-derived stem cells and then allowing them to self-assemble into the shapes of the air sacs found in human lungs, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have succeeded in creating three-dimensional lung “organoids.” The laboratory-grown lung-like tissue can be used to study diseases including idiopathic pulmonary fibrosis, which has traditionally been difficult to study using conventional methods.
“While we haven’t built a fully functional lung, we’ve been able to take lung cells and place them in the correct geometrical spacing and pattern to mimic a human lung,” said Dr. Brigitte Gomperts, an associate professor of pediatric hematology/oncology and the study’s lead author.
Idiopathic pulmonary fibrosis is a chronic lung disease characterized by scarring of the lungs. The scarring makes the lungs thick and stiff, which over time results in progressively worsening shortness of breath and lack of oxygen to the brain and vital organs. After diagnosis, most people with the disease live about three to five years. Though researchers do not know what causes idiopathic pulmonary fibrosis in all cases, for a small percentage of people it runs in their families. Additionally, cigarette smoking and exposure to certain types of dust can increase the risk of developing the disease.
To study the effect of genetic mutations or drugs on lung cells, researchers have previously relied on two-dimensional cultures of the cells. But when they take cells from people with idiopathic pulmonary fibrosis and grow them on these flat cultures, the cells appear healthy. “Scientists have really not been able to model lung scarring in a dish,” said Gomperts, who is a member of the UCLA Broad Stem Cell Research Center. The inability to model idiopathic pulmonary fibrosis in the laboratory makes it difficult to study the biology of the disease and design possible treatments.
Gomperts and her colleagues started with stem cells created using cells from adult lungs. They used those cells to coat sticky hydrogel beads, and then they partitioned these beads into small wells, each only 7 millimeters across. Inside each well, the lung cells grew around the beads, which linked them and formed an evenly distributed three-dimensional pattern. To show that these tiny organoids mimicked the structure of actual lungs, the researchers compared the lab-grown tissues with real sections of human lung.
“The technique is very simple,” said Dan Wilkinson, a graduate student in the department of materials science and engineering and the paper’s first author. “We can make thousands of reproducible pieces of tissue that resemble lung and contain patient-specific cells.”
Moreover, when Wilkinson and Gomperts added certain molecular factors to the 3-D cultures, the lungs developed scars similar to those seen in the lungs of people who have idiopathic pulmonary fibrosis, something that could not be accomplished using two-dimensional cultures of these cells.
Using the new lung organoids, researchers will be able to study the biological underpinnings of lung diseases including idiopathic pulmonary fibrosis, and also test possible treatments for the diseases. To study an individual’s disease, or what drugs might work best in their case, clinicians could collect cells from the person, turn them into stem cells, coax those stem cells to differentiate into lung cells, then use those cells in 3-D cultures. Because it’s so easy to create many tiny organoids at once, researchers could screen the effect of many drugs. “This is the basis for precision medicine and personalized treatments,” Gomperts said.
The Latest on: Precision medicine
via Google News
The Latest on: Precision medicine
- Global Precision Medicine Market Status by Manufacturers, Types and Application, History and Forecast to 2028on September 7, 2019 at 1:40 pm
Sep 07, 2019 (Reporthive Research via COMTEX) -- The Precision Medicine Market is predicted to grow at a very important CAGR within the future period because the scope and its applications are rising ...
- The Sociobehavioral Phenotype: Applying a Precision Medicine Framework to Social Determinants of Healthon September 6, 2019 at 6:07 am
Sociobehavioral phenotypes are actionable risk profiles based on empirically derived social, economic, and behavioral factors that, if applied appropriately, can help healthcare organizations address ...
- Precision Medicine Partnership Aims to Diagnose Pediatric Patientson September 5, 2019 at 10:23 am
September 05, 2019 - In a first-of-its-kind partnership in Illinois, OSF HealthCare Children’s Hospital is joining forces with Rady Children’s Institute for Genomic Medicine (RCIGM) on a precision ...
- Penn Medicine Takes a Precision Medicine Approach to Opioid Misuseon September 4, 2019 at 9:00 am
September 04, 2019 - Using a five-year, $8.9 million grant from the National Institute on Drug Abuse, psychiatry and radiology researchers from Penn Medicine will create a new Center of Excellence ...
- Precision medicine helping more people survive blood cancers: reporton September 4, 2019 at 12:02 am
The Canadian Cancer Society estimates that around 21,000 Canadians will be diagnosed with blood cancers in 2019 — representing about 10 per cent of all cancers. And those Canadians stand a ...
- Bausch loses Salix president—and turnaround architect—to precision GI companyon September 3, 2019 at 2:49 pm
McKenna will this week become the CEO of a new precision medicine drug developer, Prometheus Biosciences, the revamped byproduct of Prometheus Labs’ merger with Precision IBD. And he'll leave a hole ...
- Penn Medicine center blends radiology, psychiatry for precision approach to opioid treatmenton September 3, 2019 at 1:16 pm
Philadelphia-based Penn Medicine will establish a new Center of Excellence in which psychiatry and radiology researchers will use PET imaging to study neurobiological changes associated with opioid ...
- Precision Medicine Lowers DAPT Bleeds in STEMIon September 3, 2019 at 11:15 am
PARIS -- Selection of P2Y12 inhibitors based on genetic variants that influence response reduced bleeding events without hurting outcomes in ST-segment elevation MI (STEMI) patients getting stented, ...
- Precision electronic medicine in the brainon September 2, 2019 at 8:13 am
Periodically throughout history developments from adjacent fields of science and technology reach a tipping point where together they produce unparalleled advances, such as the Allen Brain Atlas and ...
via Bing News